Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2004 3
2005 3
2006 1
2007 2
2008 1
2009 3
2010 2
2011 1
2013 2
2014 1
2015 3
2016 4
2017 2
2018 3
2019 5
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Cannabinoid Delivery Systems for Pain and Inflammation Treatment.
Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F. Bruni N, et al. Among authors: oliaro bosso s. Molecules. 2018 Sep 27;23(10):2478. doi: 10.3390/molecules23102478. Molecules. 2018. PMID: 30262735 Free PMC article. Review.
Thermosensitive Nanocomposite Hydrogels for Intravitreal Delivery of Cefuroxime.
Sapino S, Peira E, Chirio D, Chindamo G, Guglielmo S, Oliaro-Bosso S, Barbero R, Vercelli C, Re G, Brunella V, Riedo C, Fea AM, Gallarate M. Sapino S, et al. Among authors: oliaro bosso s. Nanomaterials (Basel). 2019 Oct 15;9(10):1461. doi: 10.3390/nano9101461. Nanomaterials (Basel). 2019. PMID: 31618969 Free PMC article.
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3.
Lolli ML, Carnovale IM, Pippione AC, Wahlgren WY, Bonanni D, Marini E, Zonari D, Gallicchio M, Boscaro V, Goyal P, Friemann R, Rolando B, Bagnati R, Adinolfi S, Oliaro-Bosso S, Boschi D. Lolli ML, et al. Among authors: oliaro bosso s. ACS Med Chem Lett. 2019 Jan 28;10(4):437-443. doi: 10.1021/acsmedchemlett.8b00484. eCollection 2019 Apr 11. ACS Med Chem Lett. 2019. PMID: 30996776 Free PMC article.
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Peraldo-Neia C, Ostano P, Mello-Grand M, Guana F, Gregnanin I, Boschi D, Oliaro-Bosso S, Pippione AC, Carenzo A, De Cecco L, Cavalieri S, Micali A, Perrone F, Averono G, Bagnasacco P, Dosdegani R, Masini L, Krengli M, Aluffi-Valletti P, Valente G, Chiorino G. Peraldo-Neia C, et al. Among authors: oliaro bosso s. Cell Oncol (Dordr). 2020 Nov 19. doi: 10.1007/s13402-020-00571-z. Online ahead of print. Cell Oncol (Dordr). 2020. PMID: 33211282
Multiple catalytic activities of human 17β-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors.
Ferrante T, Adinolfi S, D'Arrigo G, Poirier D, Daga M, Lolli ML, Balliano G, Spyrakis F, Oliaro-Bosso S. Ferrante T, et al. Among authors: oliaro bosso s. Biochimie. 2020 Mar;170:106-117. doi: 10.1016/j.biochi.2019.12.012. Epub 2019 Dec 27. Biochimie. 2020. PMID: 31887335
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity.
Santos ARN, Sheldrake HM, Ibrahim AIM, Danta CC, Bonanni D, Daga M, Oliaro-Bosso S, Boschi D, Lolli ML, Pors K. Santos ARN, et al. Among authors: oliaro bosso s. Medchemcomm. 2019 Jun 27;10(8):1476-1480. doi: 10.1039/c9md00201d. eCollection 2019 Aug 1. Medchemcomm. 2019. PMID: 31673310 Free PMC article.
Ergosterol reduction impairs mitochondrial DNA maintenance in S. cerevisiae.
Cirigliano A, Macone A, Bianchi MM, Oliaro-Bosso S, Balliano G, Negri R, Rinaldi T. Cirigliano A, et al. Among authors: oliaro bosso s. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):290-303. doi: 10.1016/j.bbalip.2018.12.002. Epub 2018 Dec 12. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 30553056 Free article.
Arylpiperidines as a new class of oxidosqualene cyclase inhibitors.
Keller M, Wolfgardt A, Müller C, Wilcken R, Böckler FM, Oliaro-Bosso S, Ferrante T, Balliano G, Bracher F. Keller M, et al. Among authors: oliaro bosso s. Eur J Med Chem. 2016 Feb 15;109:13-22. doi: 10.1016/j.ejmech.2015.12.025. Epub 2015 Dec 17. Eur J Med Chem. 2016. PMID: 26745812
Mesoporous silica nanoparticles as a promising skin delivery system for methotrexate.
Sapino S, Oliaro-Bosso S, Zonari D, Zattoni A, Ugazio E. Sapino S, et al. Among authors: oliaro bosso s. Int J Pharm. 2017 Sep 15;530(1-2):239-248. doi: 10.1016/j.ijpharm.2017.07.058. Epub 2017 Jul 25. Int J Pharm. 2017. PMID: 28754510
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid.
Pippione AC, Carnovale IM, Bonanni D, Sini M, Goyal P, Marini E, Pors K, Adinolfi S, Zonari D, Festuccia C, Wahlgren WY, Friemann R, Bagnati R, Boschi D, Oliaro-Bosso S, Lolli ML. Pippione AC, et al. Among authors: oliaro bosso s. Eur J Med Chem. 2018 Apr 25;150:930-945. doi: 10.1016/j.ejmech.2018.03.040. Epub 2018 Mar 16. Eur J Med Chem. 2018. PMID: 29602039
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback